Zymeworks Inc. (ZYME) Statistics & Valuation Metrics - Stocknear

Zymeworks Inc.

NASDAQ: ZYME · Real-Time Price · USD
16.94
0.04 (0.24%)
At close: Oct 03, 2025, 3:59 PM
16.94
0.00%
After-hours: Oct 03, 2025, 04:20 PM EDT

Zymeworks Statistics

Share Statistics

Zymeworks has 75.17M shares outstanding. The number of shares has increased by 9.13% in one year.

75.17M
9.13%
7.87%
93.46%
72.94M
2,649
0.53%

Short Selling Information

The latest short interest is 7.16M, so 9.45% of the outstanding shares have been sold short.

7.16M
9.45%
12.09%
13.62

Valuation Ratios

The PE ratio is -9.05 and the forward PE ratio is -15.23. Zymeworks's PEG ratio is 1.56.

-9.05
-15.23
14.55
8.6
3.28
-9.82
1.56
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Zymeworks.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.4, with a Debt / Equity ratio of 0.05.

3.4
3.4
0.05
-0.18
-0.16
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$255.2K
$-410.35K
299
0.16
n/a

Taxes

6.08M
-5.22%

Stock Price Statistics

The stock price has increased by 34.77% in the last 52 weeks. The beta is 1.51, so Zymeworks's price volatility has been higher than the market average.

1.51
34.77%
14.73
13.39
65.37
502,150

Income Statement

In the last 12 months, Zymeworks had revenue of 76.3M and earned -122.69M in profits. Earnings per share was -1.62.

76.3M
65.11M
-119.82M
-122.69M
-105.42M
-116.61M
-1.62
Full Income Statement

Balance Sheet

The company has 66.1M in cash and 18.51M in debt, giving a net cash position of 47.6M.

66.1M
18.51M
47.6M
-830.34B
408.38M
257.63M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -110.04M and capital expenditures -3.07M, giving a free cash flow of -113.11M.

-110.04M
-3.07M
-113.11M
-1.49
Full Cash Flow Statement

Margins

Gross margin is 85.33%, with operating and profit margins of -157.03% and -160.8%.

85.33%
-157.03%
-152.82%
-160.8%
-138.16%
-157.03%
-148.24%

Dividends & Yields

ZYME does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ZYME is $20, which is 18.1% higher than the current price. The consensus rating is "Buy".

$20
18.1%
Buy
7
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

7.54
4